Amaral, T.; Schulze, M.; Sinnberg, T.; Nieser, M.; Martus, P.; Battke, F.; Garbe, C.; Biskup, S.; Forschner, A.
Are Pathogenic Germline Variants in Metastatic Melanoma Associated with Resistance to Combined Immunotherapy? Cancers 2020, 12, 1101.
https://doi.org/10.3390/cancers12051101
AMA Style
Amaral T, Schulze M, Sinnberg T, Nieser M, Martus P, Battke F, Garbe C, Biskup S, Forschner A.
Are Pathogenic Germline Variants in Metastatic Melanoma Associated with Resistance to Combined Immunotherapy? Cancers. 2020; 12(5):1101.
https://doi.org/10.3390/cancers12051101
Chicago/Turabian Style
Amaral, Teresa, Martin Schulze, Tobias Sinnberg, Maike Nieser, Peter Martus, Florian Battke, Claus Garbe, Saskia Biskup, and Andrea Forschner.
2020. "Are Pathogenic Germline Variants in Metastatic Melanoma Associated with Resistance to Combined Immunotherapy?" Cancers 12, no. 5: 1101.
https://doi.org/10.3390/cancers12051101
APA Style
Amaral, T., Schulze, M., Sinnberg, T., Nieser, M., Martus, P., Battke, F., Garbe, C., Biskup, S., & Forschner, A.
(2020). Are Pathogenic Germline Variants in Metastatic Melanoma Associated with Resistance to Combined Immunotherapy? Cancers, 12(5), 1101.
https://doi.org/10.3390/cancers12051101